Antibodies and COVID-19 Immunity: Testing, Limitations, and Therapies

Antibodies are immune proteins that bind to pathogens like SARS-CoV-2, neutralizing them and preventing cell infection. Understanding their role is crucial for navigating immunity, testing, and treatment options.

Role in Immunity

People who recover from COVID-19 typically develop antibodies that may protect against reinfection for several months. Some cross-reactivity with other coronaviruses, such as SARS-CoV, is also possible.

Antibody Testing

Two main types of antibody tests exist:

  • Serology tests: Measure antibody levels in blood, collected via venous draw or finger prick.
  • Lateral flow immunoassays: Rapid point-of-care tests using blood, saliva, or nasal fluid.

Limitations of Antibody Testing

  • False positives: Cross-reactivity with other coronaviruses or recent vaccination can skew results.
  • False negatives: Testing too early, before the body has produced detectable antibodies.
  • Timing matters: Antibody levels fluctuate over time; an optimal testing window is needed for accuracy.

Antibody Therapies

Monoclonal antibodies—lab-produced antibodies designed to target SARS-CoV-2—have demonstrated efficacy in reducing symptom severity and preventing hospitalization. Research continues on their safety, effectiveness, and evolving role in pandemic control.

Viral Infections - Related Articles